The World Health Organization is to hold a workshop in October to discuss the lessons learned from the handling of the flu pandemic and how to respond more effectively to such events in future. Topics will include the need for better co-ordination among countries, the purchasing and use of vaccines and antivirals, and the role of the pharmaceutical industry.
WHO looks at how better to respond to a pandemic
The World Health Organization is to hold a workshop in October to discuss the lessons learned from the handling of the flu pandemic and how to respond more effectively to such events in future. Topics will include the need for better co-ordination among countries, the purchasing and use of vaccines and antivirals, and the role of the pharmaceutical industry.
More from Focus On Asia
More from Scrip
• By
MariTide could give Amgen a big boost if successful in obesity, but the drug just entered Phase III. Even so, Q1 revenue rose 9% to $8.15bn and more growth is expected in 2025.
• By
On its Q1 earnings call, Moderna avoided criticizing policy changes affecting vaccines but de-emphasized its flu/COVID-19 vaccine for under-50 and prioritized cancer programs.
• By
Lilly executives told the company’s Q1 call they were not surprised at the Wegovy deal, but some analysts said it could cut into prescription growth for Zepbound.